Of course, a juicy yield today won't help you accumulate much wealth if the payout doesn't grow. Let's look at what's driving profitability for these pharmaceutical giants to see if they can keep boosting payouts over the long run. The market's recent dip brought a few big pharma stocks down to an attractive level. Which is best poised to grow its payout further? ...
It's no secret that investing in dividend-paying stocks is one of the best ways for everyday investors to create an income stream large enough to make their retirement dreams a reality. Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), and AbbVie Inc. (NYSE:ABBV) all offer yields of 3.2% or higher right now. With the average stock in the benchmark S&P 500 index paying just 1.8%, these big pharma stocks are far too attractive to ignore.
Source: Motley Fool
Related Articles:
- What's Your Retirement Vision?
- The Most Important Financial Statement When Selecting Dividend Growth Stocks
- Stock Dividends - The Gift of Nothing
- What's More Powerful Than Compound Interest?
- Dividends vs. Stock Buybacks
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.